{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-087873","form_type":"8-K","ticker":"GPCR","cik":"0001888886","company_name":"Structure Therapeutics Inc.","filed_at":"2023-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.999817+00:00","generated_at":"2026-06-12T06:30:40.722427+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Appoints Ted Love, M.D. to Board; amends director compensation policy","bullets":["Ted Love, M.D. appointed as Class III director and Chair of Compensation Committee effective August 3, 2023.","Board size reduced to seven directors; Love determined independent under Nasdaq listing standards.","Initial option grant for new non-employee directors increased to 75,000 ordinary shares (25,000 ADSs).","Annual option grant set at 37,500 ordinary shares (12,500 ADSs); post-termination exercise period extended for trust transfers.","Love receives initial grant of 75,000 shares vesting over 36 months plus cash retainers of $45,000 and $10,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-087873","json":"https://secwatch.observer/filing/0001104659-23-087873.json","markdown":"https://secwatch.observer/filing/0001104659-23-087873.md","text":"https://secwatch.observer/filing/0001104659-23-087873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1888886/000110465923087873/0001104659-23-087873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1888886/000110465923087873/tm2322858d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T06:30:40.722427+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b6f5da16d","claim":"Ted Love, M.D. was appointed as Class III director and Chair of the Compensation Committee at Structure Therapeutics Inc..","evidence_excerpt":"appointed Ted Love, M.D. to the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1888886/000110465923087873/0001104659-23-087873-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director and Chair of the Compensation Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}